HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: Role of RhoA/ROCK and MAPK pathways

1. Rupérez, M.
2. Rodrigues-Díez, R.
3. Blanco-Colio, L.M.
4. Sánchez-López, E.
5. Rodríguez-Vita, J.
6. Esteban, V.
7. Carvajal, G.
8. Plaza, J.J.
9. Egido, J.
10. Ruiz-Ortega, M.